首页> 外文期刊>Journal of gastroenterology and hepatology >Clinical value of multiband mucosectomy for the treatment of squamous intraepithelial neoplasia of the esophagus
【24h】

Clinical value of multiband mucosectomy for the treatment of squamous intraepithelial neoplasia of the esophagus

机译:多波段粘膜切除术治疗食管鳞状上皮内瘤变的临床价值

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and Aim: To evaluate the clinical value of multiband mucosectomy (MBM) for the treatment of squamous intraepithelial neoplasia of the esophagus. Methods: A total of 51 lesions located at esophagus from 43 patients were treated with MBM, among which 11 were diagnosed as middle-grade intraepithelial neoplasia, 25 as high-grade intraepithelial neoplasia, and 15 as early esophageal cancer pathologically. Primary end-points were the rate of complete endoscopic resection and the mean operation time; the second end-points were the postoperative local recurrence rate and acute plus early complications. The histopathological results were compared between pre-MBM biopsy and MBM specimens. All patients were followed up endoscopically. Results: A total of 52 MBM procedures with 180 resections were performed in 43 patients. The complete endoscopic resection was achieved in 92.3% (95% confidence interval [CI] 81.8-96.9%). The sizes of the lesions ranged from 10??8mm to 25??23mm. The mean operation time is 37??5min. The operative acute bleeding complication was 7.6% (95% CI 3-18.1%); no perforations occurred. Early complications consisted of delayed bleeding (one patient 1.9%; 95% CI 0.3-10.1%) and slight esophageal stenosis (one patient). The histopathological diagnosis of 26 cases (51%) was consistent between biopsy and MBM samples, while 20 lesions exhibited higher grade dysplasia. The local recurrence rate was 6.9% (3/43) at 1 year, 9.3% (4/43) at 2 years, and 9.3% at 2.5 years. No death occurred during follow-up. Conclusions: MBM is a safe and effective technique for the treatment of early esophageal cancer and precancerous lesions. ? 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.
机译:背景与目的:评价多频带粘膜切除术(MBM)在食管鳞状上皮内瘤变中的临床价值。方法:43例患者共51处食道病变行MBM治疗,其中11例经病理诊断为中度上皮内瘤变,25例为高级别上皮内瘤变,15例经病理证实为早期食道癌。主要终点为内镜完全切除率和平均手术时间。第二个终点是术后局部复发率和急性加早期并发症。在MBM活检前和MBM标本之间比较了组织病理学结果。所有患者均接受内镜随访。结果:43例患者共进行了52例MBM手术,并进行了180次切除。完整的内窥镜切除术达到92.3%(95%置信区间[CI] 81.8-96.9%)。病变的大小从10毫米8毫米到25毫米23毫米不等。平均手术时间为37±5分钟。手术急性出血并发症为7.6%(95%CI 3-18.1%);没有发生穿孔。早期并发症包括延迟出血(一名患者1.9%; 95%CI 0.3-10.1%)和轻度食管狭窄(一名患者)。活检和MBM样本之间的组织病理学诊断为26例(51%),而20个病变表现为高度不典型增生。 1年局部复发率为6.9%(3/43),2年局部复发率为9.3%(4/43),而2.5年局部复发率为9.3%。随访期间未发生死亡。结论:MBM是治疗早期食管癌和癌前病变的一种安全有效的技术。 ? 2013年《胃肠病和肝病学杂志》和Wiley Publishing Asia Pty Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号